De Novo Status Epilepticus in patients with COVID-19
- PMID: 32407609
- PMCID: PMC7273010
- DOI: 10.1002/acn3.51071
De Novo Status Epilepticus in patients with COVID-19
Abstract
Neurological complications are increasingly recognized with SARS-CoV-2, the causative pathogen for COVID-19. We present a single-center retrospective case series reporting the EEG and outcome of de novo status epilepticus (SE) in two African-American women with laboratory-confirmed SARS-CoV-2 virus. SE was the initial presentation in one asymptomatic individual. Patient 2 had COVID-19 pneumonia, and fluctuating mental status that raised the suspicion of subclinical SE. The patient with older age and higher comorbidities failed to recover from the viral illness that has no definitive treatment.
© 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Conflict of interest statement
None.
Figures




References
-
- Mao L, Wang M, Chen S, et al. Neurological Manifestations of Hospitalized Patients with COVID‐19 in Wuhan, China: a retrospective case series study. medRxiv 2020.
-
- Thebault R. Ba Tran AWV. The coronavirus is infecting and killing black Americans at an alarmingly high rate. 2020. https://www.washingtonpost.com/
-
- Gofton TE, Gaspard N, Hocker SE, et al. New onset refractory status epilepticus research. Neurology 2019;92(17):802–810. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous